
Miracle
Miracle is a YC Winter 2023 (W23) company. Based in San Francisco, CA, USA. Team of 6.
About Miracle
Summary
Miracle builds a clinical trial operations platform for clinical-stage biopharmaceutical companies. It pulls data from multiple trial systems, including CROs and study sites, into a single automated dashboard, replacing manual tracking in spreadsheets. Teams use it to monitor enrollment, flag site performance issues, and make decisions in minutes rather than days or weeks.
Business model
Paid plans priced on a subscription basis, as indicated by a public pricing page.
Go-to-market
Clinical operations teams at biopharma companies are the primary buyers; customers can book a demo or self-start through the website.
From the Y Combinator listing
Accelerate clinical trials with real-time, actionable insights
Miracle is the control room for clinical trials. Our platform consolidates data from multiple trial systems into real-time dashboards, delivering automated insights that empower clinical-stage biopharmaceutical companies to streamline operations, reduce manual workflows, and accelerate data-driven decision-making. By transforming complex trial data into actionable insights, Miracle helps biopharma teams speed up clinical trials, and ultimately, improve patient outcomes.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA
- 6
- Active
- Early
Founders (1)
- Jin Kim
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works